Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
This comparison highlights essential contrasts between Zero Based and Incremental budgeting, focusing on allocation, rigor, and outcomes.
17,319 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
A top China logistics platform generated $1.8 billion in revenue last year, yet one investor cashed out a $6 million ...
Super Micro Computer delivered a blowout Q2 as AI infrastructure demand drives orders for its Data Center Building Bl...
Tower Semiconductor stock jumped today after a strategic move into AI networking. This article breaks down the deal, ...
Citi analysts say Netflix is better positioned to lift pricing now that licensing and regulatory overhangs have eased...
A major EV maker partners with Uber on a robotaxi plan, sending ripples through the market. This guide breaks down wh...
Alibaba heads into 2026 with two clear catalysts. This analysis lays out the two big predictions, explains why they c...
Could Starbucks be hiding dividend upside under a modest price tag? This guide breaks down how to judge whether starb...
Bitcoin slipped from a brief rally as geopolitical headlines weighed on risk sentiment. Traders are watching on-chain...
Amazon stock fell about 3% on Friday as macro uncertainty and doubts about a $200B AI capital plan for 2026 weigh on ...
Exxon Mobil topped expectations in Q1 as LNG and Guyana projects accelerate. Investors are eyeing exxon mobil’s next ...
Central Valley peach growers confront a costly and abrupt pivot after Del Monte closures. About 3,000 acres will be u...